title: Cost utility of drugs for multiple sclerosis. Methods used don't calculate true benefit.
authors.forename: R
authors.initials: R
authors.lastname: Richards
authors.forename: A
authors.initials: A
authors.lastname: Burls
authors.forename: N
authors.initials: N
authors.lastname: Payne
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D015331:Cohort Studies; D006801:Humans; D000068556:Interferon beta-1a; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D000276:Adjuvants, Immunologic; D000068576:Interferon beta-1b; D016899:Interferon-beta; D000068556:Interferon beta-1a